ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

1 Stock Under $50 on Our Watchlist and 2 to Ignore

CFLT Cover Image

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

This is precisely where StockStory comes in - we do the heavy lifting to identify companies with solid fundamentals so you can invest with confidence. Keeping that in mind, here is one stock under $50 that could 10x and two best left ignored.

Two Stocks Under $50 to Sell:

Shyft (SHYF)

Share Price: $10.02

Notably receiving an order from FedEx for electric vehicles, Shyft (NASDAQ: SHYF) offers specialty vehicles and truck bodies for various industries.

Why Do We Avoid SHYF?

  1. Customers postponed purchases of its products and services this cycle as its revenue declined by 12.5% annually over the last two years
  2. Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 5.3 percentage points
  3. Diminishing returns on capital suggest its earlier profit pools are drying up

Shyft is trading at $10.02 per share, or 14.3x forward price-to-earnings. If you’re considering SHYF for your portfolio, see our FREE research report to learn more.

10x Genomics (TXG)

Share Price: $10.92

Founded in 2012, 10x Genomics (NASDAQ: TXG) develops single-cell and spatial genomics solutions, enabling researchers to analyze biological systems at high resolution.

Why Do We Pass on TXG?

  1. Cash-burning history makes us doubt the long-term viability of its business model
  2. Push for growth has led to negative returns on capital, signaling value destruction, and its decreasing returns suggest its historical profit centers are aging

At $10.92 per share, 10x Genomics trades at 2.1x forward price-to-sales. Dive into our free research report to see why there are better opportunities than TXG.

One Stock Under $50 to Watch:

Confluent (CFLT)

Share Price: $32.01

Started in 2014 by the team of engineers at LinkedIn who originally built it as an internal tool, Confluent (NASDAQ: CFLT) provides infrastructure software for organizations that makes it easy and fast to collect and move large amounts of data between different systems.

Why Are We Fans of CFLT?

  1. Average billings growth of 26.4% over the last year enhances its liquidity and shows there is steady demand for its products
  2. Platform plays a pivotal role in customer workflows as its net revenue retention rate punches in at 119%
  3. Projected revenue growth of 20.8% for the next 12 months suggests its momentum from the last three years will persist

Confluent’s stock price of $32.01 implies a valuation ratio of 9x forward price-to-sales. Is now the right time to buy? Find out in our full research report, it’s free.

Stocks We Like Even More

The Trump trade may have passed, but rates are still dropping and inflation is still cooling. Opportunities are ripe for those ready to act - and we’re here to help you pick them.

Get started by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years.

Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Sterling Infrastructure (+1,096% five-year return). Find your next big winner with StockStory today for free.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.